Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets remain in green
Tue, 4 Jun 11:30 am

Indian share markets have remained in green during the previous two hours of trade. Healthcare and capital gods sectors are leading the gains while information technology and consumer durables are facing the maximum selling pressures.

The BSE Sensex is up by 91 points and NSE-Nifty is up by 29 points. BSE Mid Cap index is up by 0.5% while BSE Small Cap index is up by 0.6%. The rupee is trading at 56.66 to the US dollar.

All but three steel shares, Jindal Steel, Tayo Rolls and Gujarat Mineral Development are trading in green with JSW Ispat and Maharashtra Seamless leading the gains. State-run Steel Authority of India (SAIL) has recorded the best-ever production of saleable steel for May at 1.1 million tonnes (MT), up by 11% over the corresponding month previous year. The production of value added and special steel too surged around 8% during the month against the corresponding month of the last year. Meanwhile, the production of crude steel at 1.152 MT for the month was also the highest. The production of the company is likely to further improve in the coming months as its ongoing Rs 619 bn expansion is getting progressively commissioned.

SAIL has reported a decline of 71.7% in its net profit at Rs 4.5 bn in 4QFY13 as compared to net profit of Rs 15.8 bn in the same quarter previous year. Total income from operation of the company has decreased by 9.9% to Rs 123.3 bn as compared to Rs 136.9 bn in the corresponding quarter of last year. SAIL's share is trading up by 1%.

All Indian Pharma shares are trading in the green with Orchid Chemicals and Piramal Enterprises leading the gains. According to a leading financial news daily, the European Union's Anti Trust Commission may impose a fine on Ranbaxy Labs for delaying the launch of the low- cost generic version of Citalopram, a blockbuster anti-depressant in the European Union market. An agency report from Brussels has said that the European regulator would press ahead with pay-for-delay deals in the pharmaceutical sector this month, imposing fines on Ranbaxy and eight other drug manufacturers for limiting access of cheaper products to the market. The competition watchdog, in its preliminary view in July 2012, has held that the patent settlement agreements between Lundbeck, the Danish innovator firm and other generic firms, including Ranbaxy, has been aimed at preventing the market entry of cheaper generic medicines, violating EU's antitrust rules. Besides Ranbaxy, other firms which have inked similar patent settlement agreements with Lundbeck to launch their generic version include Merck, Generics UK, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma and AL Industrier. Ranbaxy's share is trading up by 2.7%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian share markets remain in green". Click here!

  

Related Views on News

COAL INDIA Announces Quarterly Results (2QFY21); Net Profit Down 16.3% (Quarterly Result Update)

Nov 25, 2020 | Updated on Nov 25, 2020

For the quarter ended September 2020, COAL INDIA has posted a net profit of Rs 30 bn (down 16.3% YoY). Sales on the other hand came in at Rs 212 bn (up 3.8% YoY). Read on for a complete analysis of COAL INDIA's quarterly results.

COAL INDIA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of COAL INDIA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of COAL INDIA. Also includes updates on the valuation of COAL INDIA.

COAL INDIA Announces Quarterly Results (1QFY21); Net Profit Down 55.1% (Quarterly Result Update)

Sep 23, 2020 | Updated on Sep 23, 2020

For the quarter ended June 2020, COAL INDIA has posted a net profit of Rs 21 bn (down 55.1% YoY). Sales on the other hand came in at Rs 185 bn (down 25.9% YoY). Read on for a complete analysis of COAL INDIA's quarterly results.

COAL INDIA 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of COAL INDIA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of COAL INDIA. Also includes updates on the valuation of COAL INDIA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Mar 3, 2021 (Close)

S&P BSE SENSEX 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS